Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis

by Jennifer Furin, Grania Brigden, Erica Lessem, Michael Rich, Laura Vaughan, Sharonann Lynch
Published 2016-03-01

Advances in clinical trial design for development of new TB treatments-Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from B...

by Grania Brigden, Nguyen Viet Nhung, Alena Skrahina, Norbert Ndjeka, Dennis Falzon, Matteo Zignol
Published 2019-10-01

Tuberculosis recurrence over a 7-year follow-up period in successfully treated patients in a routine program setting in China: a prospective longitudinal study

by Yan Lin, Haoxiang Lin, Lixin Xiao, Yongming Chen, Xu Meng, Xianglin Zeng, Chun Chang, Grania Brigden
Published 2021-09-01

Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.

by Carole D Mitnick, Carly A Rodriguez, Marita L Hatton, Grania Brigden, Frank Cobelens, Martin P Grobusch, Robert Horsburgh, Christoph Lange, Christian Lienhardt, Eyal Oren, Laura J Podewils, Barbara Seaworth, Susan van den Hof, Charles L Daley, Agnes C Gebhard, Fraser Wares, RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative)
Published 2016-01-01